Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Herbert Virgin and Davide Corti.
Connection Strength

1.564
  1. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021 10; 598(7880):342-347.
    View in: PubMed
    Score: 0.241
  2. After the pandemic: perspectives on the future trajectory of COVID-19. Nature. 2021 08; 596(7873):495-504.
    View in: PubMed
    Score: 0.239
  3. A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature. 2020 08; 584(7821):353-363.
    View in: PubMed
    Score: 0.223
  4. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
    View in: PubMed
    Score: 0.221
  5. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 09 03; 373(6559):1109-1116.
    View in: PubMed
    Score: 0.060
  6. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2021 09; 597(7874):103-108.
    View in: PubMed
    Score: 0.060
  7. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021 09; 597(7874):97-102.
    View in: PubMed
    Score: 0.060
  8. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science. 2021 08 06; 373(6555):648-654.
    View in: PubMed
    Score: 0.060
  9. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 04 29; 184(9):2332-2347.e16.
    View in: PubMed
    Score: 0.058
  10. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021 05; 593(7857):136-141.
    View in: PubMed
    Score: 0.058
  11. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
    View in: PubMed
    Score: 0.058
  12. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell. 2021 03 04; 184(5):1171-1187.e20.
    View in: PubMed
    Score: 0.058
  13. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 11 20; 370(6519):950-957.
    View in: PubMed
    Score: 0.057
  14. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell. 2020 11 12; 183(4):1024-1042.e21.
    View in: PubMed
    Score: 0.056
  15. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. Cell Host Microbe. 2020 09 09; 28(3):475-485.e5.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.